Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...

Australia's taken another step in HIV prevention, with the TGA approving long-acting drug lenacapavir—but access is vital, ...

Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...

HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

The researchers reviewed major studies of both PrEP for HIV prevention and aspirin for heart attack prevention. They found that both had similar low rates of serious side effects. Aspirin users rarely ...

What is Pre-Exposure Prophylaxis (PrEP)? Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy that enables HIV-negative people to stay HIV-negative by taking anti-HIV drugs (also called ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce ...

CDC: New HIV Pre-Exposure Prophylaxis Guidelines New clinical guidelines on HIV pre-exposure prophylaxis (PrEP) recommend the use of anti-HIV drugs by uninfected patients who are at substantial risk ...

Thiruvananthapuram The death of a 19-year-old college student at Palakkad due to rabies, even after she had been administered the immunoglobulin serum and full vaccination as per schedule, has created ...